RS

Ravi Shankar Singh

Director Director DIN 03010302
DIN 03010302 First appointment Aug 2010 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Shankar Singh

Data last updated:

Ravi Shankar Singh was a Director at Annulus Pharmaceuticals Private Limited (2016–2019) and Managing Director at Lycos Pharmaceuticals Private Limited (from 2010). The companies operate in Business Services.

DIN 03010302
Primary Designation Director
Industry Business Services
First Appointment 17 Aug 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Oct 20162016₹10.8 Lakh (FY 2025)Active
Managing Director17 Aug 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lycos Pharmaceuticals Private Limited
Annulus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ravi Shankar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Shankar Singh

Ravi Shankar Singh was first appointed on 17 Aug 2010 as Managing Director at Lycos Pharmaceuticals Private Limited. The most recent appointment on record is 05 Oct 2016 at Annulus Pharmaceuticals Private Limited.

Ravi Shankar Singh held 2 earlier board appointments: Annulus Pharmaceuticals Private Limited (Director, 05 Oct 2016 to 22 Apr 2019); Lycos Pharmaceuticals Private Limited (Managing Director, from 17 Aug 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available